Oxford starts human testing of Nipah virus vaccine

Nipah was first identified about 25 years ago in Malaysia and has led to outbreaks in Bangladesh, India and Singapore. The first participants in the Oxford trial received doses of the vaccine over the last week. The shot is based on the same technology as the one used in AstraZeneca and Serum Institute of India's COVID-19 shots.

Related Keywords

Bangladesh ,Malaysia ,Bengaluru ,Karnataka ,India ,Singapore ,Kerala ,Leroy Leo ,Devika Syamnath ,Us National Institute Of Allergy ,Astrazeneca ,Oxford Vaccine Group ,University Pandemic Sciences Institute ,World Health Organization ,Reuters ,Serum Institute Of India ,University Of Oxford ,Coalition For Epidemic Preparedness Innovations ,Serum Institute ,Pandemic Sciences Institute ,Epidemic Preparedness Innovations ,National Institute ,World Health ,Nipah Virus ,Experimental Vaccine ,Kerala State ,Brain Swelling ,Oxford ,